Mymetics Corp (MYMX)

[Work Harder]

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans

Georgia D. Tomaras

Juliana McElrath

NIAID HIV Vaccine Trials Network (HVTN) 076, 088, 086, 096, 097, 205 Study TeamsShow fewer authors

https://www.nature.com/articles/s41541-021-00305-8

https://twitter.com/_R_Foundation?ref_src=twsrc%5Etfw%7Ctwcamp%5Eembeddedtimeline%7Ctwterm%5Eprofile%3A_R_Foundation%7Ctwgr%5EeyJ0Zndfc2tlbGV0b25fbG9hZGluZ18xMzM5OCI6eyJidWNrZXQiOiJjdGEiLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X3NwYWNlX2NhcmQiOnsiYnVja2V0Ijoib2ZmIiwidmVyc2lvbiI6bnVsbH0sInRmd19ob3Jpem9uX3R3ZWV0X2VtYmVkXzk1NTUiOnsiYnVja2V0IjoiaHRlIiwidmVyc2lvbiI6bnVsbH0sInRmd19zZW5zaXRpdmVfbWVkaWFfaW50ZXJzdGl0aWFsXzEzOTYzIjp7ImJ1Y2tldCI6ImNvbnRyb2wiLCJ2ZXJzaW9uIjo0fSwidGZ3X2V4cGVyaW1lbnRzX2Nvb2tpZV9leHBpcmF0aW9uIjp7ImJ1Y2tldCI6MTIwOTYwMCwidmVyc2lvbiI6bnVsbH19&ref_url=https%3A%2F%2Fwww.r-project.org%2F

Q&A with Georgia Tomaras, Professor in Surgery and Immunology Researcher

Thursday, February 10, 2022

Our colleagues [who submitted the proposal to the NIH] approached us for working on a component of a global influenza vaccine program, which is to develop standardized methods to evaluate the immune system. We had built a program from HIV and other pathogens where
we are standardizing, qualifying, and validating immune assays that we can use in clinical trials. So when [the grant] was awarded, it was clear that we would need new support for it and the School of Medicine fortunately supported new lab space and equipment.

Georgia Tomaras, PhD, joined Duke in 1998 as a postdoctoral fellow in the Center for AIDS Research to investigate T cells as they relate to human immunodeficiency virus (HIV) immunity. She received her doctor of philosophy
degree from the State University of New York Upstate (SUNY-Upstate) Medical University. Today, Dr. Tomaras holds joint faculty appointments in the Duke Departments of Surgery, Immunology, and Molecular Genetics and Microbiology, and is

Director of the Duke Center for Human Systems Immunology, Immunological Sciences and recently became the Director of the Duke Center for AIDS Research.

Editor's Note: The initial publication of this story incorrectly omitted 'departments of surgery' from the statement regarding Dr. Tomaras's NIH funding acknowledgement.

https://surgery.duke.edu/news/qa-georgia-tomaras-professor-surgery-and-immunology-researcher

Duke Research and Discovery @RTP was born in 2020 when Duke University leased a 273,000 square foot facility in the Parmer RTP research and development campus, former home to pharmaceutical maker GlaxoSmithKline.

https://medschool.duke.edu/research/duke-research-and-discovery-rtp